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Thrombolytics in Pediatric Stroke: Imaging Modalities
Katherine Au, Dr. Mary Hollist D.O., Amanda Barber AGPCNP-BC., Dr. Batool Kirmani M.D.
Inova Fairfax Medical Hospital, Department of Neuroscience

Abstract
We report the importance of the hyperacute MRI and collaborative
decision-making process for acute ischemic stroke, particularly, in
pediatrics. For patients who present with clinical features suggestive
of an acute ischemic stroke, there is concern of utilizing
thrombolysis given the possibility of treating a mimic.
A case of pediatric management with intravenous tissue
plasminogen activator (IV tPA) is referenced to emphasize its
efficacy in children, and to highlight the diagnostic difficulties
associated with the care of pediatric patients with suspected stroke.

Introduction
§ Stroke is among the top 12 causes of death in children. It is an
under recognized condition that is associated with long-term
neurological deficits and a mortality rate of ~ 10%1-5

Conclusion

Discussion
§ Up to 2% of children with acute stroke who qualify for
thrombolytic treatment have reported treatment with tPA10
§ IV tPA has been the main intervention for the management of
pediatric stroke and has shown good outcomes

Ø With an incidence of 2.5-13 people per 100,000, pediatric stroke is
often under-recognized, delaying diagnosis and precluding timesensitive tPA treatment for many who may benefit11
Ø Up to 40% of pediatric cases are given an incorrect initial
diagnosis of stroke mimics13

§ However, data on safety is lacking due to a shortage of
randomized controlled trials in children with stroke10
§ Accurate and timely diagnosis is of great importance to minimize
significant neurologic deficits

Ø tPA administration in pediatric populations suspected of acute
stroke is not well established but has yielded good outcomes

§ A joint decision-making process with both a pediatric neurologist
and vascular neurologist are recommended due to frequent stroke
mimics in children

Ø While MRI is known to have good sensitivity and specificity, careful
observation is warranted due to the frequency of false negatives of
subtly apparent areas of restricted diffusion and misdiagnosis in the
hyperacute setting10

§ Use of hyperacute MRI (hMRI) for a more effective informed
management decision is appropriate as it has been demonstrated to
quickly and accurately identify ischemic stroke within minutes12
§ To facilitate appropriate neuroimaging, we have proposed a
standardized diagnostic imaging flow chart [See Figure 1]

Ø hMRI should be considered and used as an adjunctive screening
tool for effective informed management in patients suspected of
stroke to quickly enable tPA treatment when appropriate
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Case Summary
A 14-year old female with a history of (right or left) thalamic
stroke who presented with neurological symptoms consistent
with acute stroke. On initial read, MRI of her brain was
indeterminate and showed no frank evidence of cerebral
infarction. Further inspection showed an area of restricted
diffusion which clinically correlated to her symptoms in the
dorsal aspect of the left midbrain. There was no evidence of
vessel wall irregularities, high grade stenosis or dissection. This
patient was administered tPA over the course of 1 hour and the
following day, her symptoms resolved.
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